|
Training Program in Cancer Biology
|
5T32CA078207-19
|
$554,252
|
|
AARONSON, STUART
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
WalkIT: Neighborhood walkability and moderation of adaptive walking interventions
|
5R01CA198915-04
|
$568,727
|
|
ADAMS, MARC
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Studies of Normal and Neoplastic Prostate
|
5U01CA015062-33
|
$215,048
|
$43,010
|
AHMED, KHALIL
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Mutagenesis and migration in glioblastoma cells
|
1R21CA220111-01A1
|
$179,240
|
|
AHN, EUN HYUN
|
UNIVERSITY OF WASHINGTON
|
|
Mapping cancer micro-environments for acute leukemia
|
5R01CA202025-03
|
$455,870
|
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-05
|
$234,166
|
$35,125
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
p63 as a novel factor promoting pregnancy-induced HER2-positive breast cancer
|
5K22CA190653-03
|
$157,743
|
|
ALEXANDROVA, EVGUENIA
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance
|
5F30CA220847-02
|
$49,524
|
|
ALI, MOIEZ
|
DUKE UNIVERSITY
|
|
Single-Cell Measurement of Lipid Signaling in Colorectal Cancer
|
5R01CA177993-05
|
$575,397
|
|
ALLBRITTON, NANCY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Novel Molecular Therapies of Prostate Cancer
|
5P01CA140043-09
|
$1,222,825
|
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
NANOTHERAPEUTIC STRATEGY FOR MULTIDRUG RESISTANT TUMORS
|
5R01CA119617-04
|
$362,876
|
$119,749
|
AMIJI, MANSOOR
|
NORTHEASTERN UNIVERSITY
|
|
RIP140 as a mediator of Estrogen Receptor action in tumor associated macrophages
|
5F31CA220978-02
|
$35,725
|
|
ANDREANO, KAITLYN
|
DUKE UNIVERSITY
|
|
Targeting the adenosine A2A receptor immune checkpoint in lung cancer patients
|
5R01CA201124-03
|
$259,646
|
|
ANTONIA, SCOTT
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
A Novel Values-based Intervention to Increase Endocrine Therapy Adherence among Breast Cancer Survivors
|
1R21CA218723-01A1
|
$207,450
|
|
ARCH, JOANNA
|
UNIVERSITY OF COLORADO
|
|
Reversing Cellular immortality in cancer
|
5R35CA197563-04
|
$962,915
|
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
SPORE in Breast Cancer
|
2P50CA098131-06
|
$2,300,000
|
$92,000
|
ARTEAGA, CARLOS
|
VANDERBILT UNIVERSITY
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-22
|
$1,906,536
|
$266,915
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-10
|
$128,678
|
$19,302
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Telomeres, telomerase and chemotherapy: Bench to bedside
|
7R01CA077091-05
|
$338,540
|
$338,540
|
Au, Jessie
|
OPTIMUM THERAPEUTICS, LLC
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-34
|
$417,899
|
$62,685
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Postdoctoral Training Program in Cancer Survivorship
|
5R25CA122061-11
|
$236,400
|
|
AVIS, NANCY
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
(PQC3) Ethnicity-determined immune response and DCIS outcome
|
5R01CA194600-04
|
$179,518
|
|
BADVE, SUNIL
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
San Juan Minority - Based Community Clinical Oncology Program
|
2U10CA052667-18
|
$787,595
|
$110,263
|
BAEZ, LUIS
|
SAN JUAN HEALTH DEPARTMENT
|
|
Vitamin D and Ovarian Cancer Prevention and Treatment
|
5R01CA111334-04
|
$244,382
|
$12,219
|
BAI, WENLONG
|
UNIVERSITY OF SOUTH FLORIDA
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
3U10CA032102-29S1
|
$628
|
$144
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
3U10CA037429-24S1
|
$464,405
|
$51,085
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
DNA-linked dendrimer nanoparticle systems for cancer diagnosis and treatment
|
5R01CA119409-04
|
$474,360
|
$118,590
|
Baker, James
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Southwest Oncology Group
|
5U10CA027057-29
|
$262,397
|
$60,351
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
5U10CA032102-29
|
$9,490,764
|
$2,182,876
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
7U10CA037429-24
|
$16,768,272
|
$1,844,510
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
The DNA adductome of lung carcinogenesis
|
1R01CA220376-01A1
|
$348,000
|
|
BALBO, SILVIA
|
UNIVERSITY OF MINNESOTA
|
|
Oncogenic Ras-induced macropinocytosis: A new paradigm for metabolic adaptation
|
5R35CA210263-03
|
$968,501
|
|
BAR-SAGI, DAFNA
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
A-to-I microRNA Editing and Melanoma Metastasis
|
1R21CA219958-01A1
|
$208,800
|
|
BARELI, MENASHE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
WUMC-Cancer and Leukemia Group B
|
5U10CA077440-11
|
$334,932
|
$150,719
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
University of Texas MD Anderson SPORE in Ovarian Cancer
|
5P50CA083639-09
|
$2,180,816
|
$436,163
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
ARHI (DIRAS3) in Autophagy and Dormancy of Ovarian Cancer
|
5R01CA135354-08
|
$380,000
|
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Clinical Studies of Multidrug Resistance Reversal
|
Z01 BC 010620
|
$113,917
|
$11,392
|
Bates, Susan
|
CCR (NCI)
|
|
Proliferation and Differentiation of Bladder Epithelial Cells in Regeneration and Malignancy
|
2R01CA157877-06A1
|
$507,988
|
|
BEACHY, PHILIP
|
STANFORD UNIVERSITY
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-24
|
$1,880,470
|
$225,656
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
The Gulf Coast MBCCOP
|
7U10CA128536-02
|
$539,869
|
$75,582
|
BEEKER, THADDEUS
|
PROVIDENCE HOSPITAL (MOBILE, AL)
|
|
Linking Oncogenic Signaling to Tumor Metabolism
|
5R00CA194192-04
|
$230,670
|
|
BEN-SAHRA, ISSAM
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Eastern Cooperative Oncology Group Clinical Trials
|
5U10CA017145-33
|
$452,395
|
$67,859
|
BENSON, AL
|
NORTHWESTERN UNIVERSITY
|
|
Inter-regulatory function of immune-modulation and angiogenesis in cancer
|
5R01CA201537-03
|
$362,569
|
|
BERGERS, GABRIELE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Geisinger Clinical Oncology Program
|
2U10CA035448-25
|
$599,474
|
$17,984
|
BERNATH, ALBERT
|
WEIS CENTER FOR RESEARCH-GEISINGER CLINC
|
|
An assessment of whether aspirin and/or vitamin D improves breast cancer outcomes in Black women and the modifying effect of genetic variants
|
5K01CA212056-02
|
$133,775
|
|
BETHEA, TRACI
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Ubiquilin1 regulates EMT and metastasis of human lung adenocarcinoma
|
5R01CA193220-04
|
$352,275
|
|
BEVERLY, LEVI
|
UNIVERSITY OF LOUISVILLE
|
|
Translational Molecular and Cellular Imaging Technologies for Prostate Tumor Pathology
|
5R33CA196458-03
|
$362,020
|
|
BHARGAVA, ROHIT
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
|
Research Training Program in Basic and Translational Oncology
|
5T32CA183926-05
|
$247,189
|
|
BHATIA, RAVI
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Gynecologic Oncology Group Statistical and Data Center
|
5U10CA037517-24
|
$4,682,025
|
$3,886,081
|
BLESSING, JOHN
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Cancer and Leukemia Group B - The Ohio State University
|
5U10CA077658-11
|
$450,518
|
$202,733
|
BLOOMFIELD, CLARA
|
OHIO STATE UNIVERSITY
|
Total relevant funding to Taxol for this search: $63,801,767
|